Leerink Partnrs Predicts Gilead Sciences Q1 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Gilead Sciences in a report issued on Wednesday, February 12th. Leerink Partnrs analyst D. Graybosch anticipates that the biopharmaceutical company will post earnings of $1.98 per share for the quarter. Leerink Partnrs currently […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Gilead Sciences in a report issued on Wednesday, February 12th. Leerink Partnrs analyst D. Graybosch anticipates that the biopharmaceutical company will post earnings of $1.98 per share for the quarter. Leerink Partnrs currently […]
-inc-logo-1200x675.PNG?v=20210312142656&w=240&h=240&zc=2){kind=logo}
